Who are Cytek Biosciences, Inc.'s main suppliers?

Cytek Biosciences, Inc. (CTKB) key suppliers include: COHERENT-NA-INC, Becton, Dickinson and Company, Becton, Dickinson and Company, Waters Corporation. View the full supplier network at chainsifter.com/chain/CTKB.

Who are Cytek Biosciences, Inc.'s major customers?

Cytek Biosciences, Inc. (CTKB) key customers include: USGOV-DEPARTMENT-OF-HEALTH-AND-HUMAN-SERVICES, USGOV-DEPARTMENT-OF-VETERANS-AFFAIRS, COHERENT-NA-INC, CYTEK-BIOSCIENCES-PTE-LTD, Becton, Dickinson and Company and 12 more. View the full customer network at chainsifter.com/chain/CTKB.

What sector is Cytek Biosciences, Inc. in?

Cytek Biosciences, Inc. (CTKB) operates in the general sector. ChainSifter tracks its verified supply chain relationships including suppliers, customers, and strategic partners.

Cytek Biosciences, Inc. Supplier List (CTKB): 4 Verified Suppliers

4Suppliers

17Customers

1Debt Items

20Related Chains

Source-Backed Evidence Depth

Cytek Biosciences, Inc. (CTKB) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.

23Total relationships

3Distinct source URLs

7High confidence

0.741Average confidence

2026-09-13Latest database update

ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.

Cytek Biosciences, Inc. Suppliers

Ticker	Name	Confidence	Evidence
COHERENT-NA-INC	COHERENT-NA-INC	92%	Pursuant to the Coherent Agreement, Coherent has agreed to sell and supply to us, Cytek Wuxi, and Cytek Singapore, on a non-exclusive basis, laser products manufactured by Coherent.
BDX	Becton, Dickinson and Company	72%	. See Note 18 to our consolidated financial statements included elsewhere in this Annual Report on Form 10-K for information regarding ongoing legal proceedings. We could incur substantial costs and …
BDX	Becton, Dickinson and Company	72%	Reciprocal relationship from BDX graph: Reciprocal relationship from CTKB graph: . See Note 18 to our consolidated financial statements included elsewhere in this Annual Report on Form 10-K for infor…
WAT	Waters Corporation	72%	Reciprocal relationship from WAT graph: Reciprocal relationship from CTKB graph: Reciprocal relationship from WAT graph: Reciprocal relationship from CTKB graph: Reciprocal relationship from WAT grap…

Cytek Biosciences, Inc. Customers

Ticker	Name	Confidence	Evidence
USGOV-DEPARTMENT-OF-HEALTH-AND-HUMAN-SERVICES	USGOV-DEPARTMENT-OF-HEALTH-AND-HUMAN-SERVICES	95%	USAspending awards from Department of Health and Human Services: $2,661,270 across 9 awards. 75N92023P00194 PURCHASE OF AMNIS IMAGESTREAM MKII SYSTEM; 75N91023P00315 BASE PERIOD - MAINTENANCE SERVICE…
USGOV-DEPARTMENT-OF-VETERANS-AFFAIRS	USGOV-DEPARTMENT-OF-VETERANS-AFFAIRS	95%	USAspending awards from Department of Veterans Affairs: $106,221 across 1 awards. 36C25923P1005 IMAGESTREAM X MKII MAINTENANCE SERVICE PLAN \| Qwen corrected direction: Explicit government contract aw…
COHERENT-NA-INC	COHERENT-NA-INC	85%	with Coherent NA, Inc. and certain of its affiliates (collectively, “Coherent”), which was amended on August 12, 2025 by Contract Amendment No. 1 (as amended, the “Coherent Agreement”) to extend the …
CYTEK-BIOSCIENCES-PTE-LTD	CYTEK-BIOSCIENCES-PTE-LTD	85%	with Coherent NA, Inc. and certain of its affiliates (collectively, “Coherent”), which was amended on August 12, 2025 by Contract Amendment No. 1 (as amended, the “Coherent Agreement”) to extend the …
BDX	Becton, Dickinson and Company	72%	Reciprocal relationship from BDX graph: Reciprocal relationship from CTKB graph: Reciprocal relationship from BDX graph: Reciprocal relationship from CTKB graph: Reciprocal relationship from BDX grap…
BDX	Becton, Dickinson and Company	72%	. See Note 18 to our consolidated financial statements included elsewhere in this Annual Report on Form 10-K for information regarding ongoing legal proceedings. We could incur substantial costs and …
LAB	Standard BioTools Inc.	72%	stics companies that design, manufacture and market flow cytometry instruments, accessories, consumables and software for cell analysis and/or provide services related to the same. An increasing numb…
LAB	Standard BioTools Inc.	72%	Reciprocal relationship from LAB graph: Reciprocal relationship from CTKB graph: stics companies that design, manufacture and market flow cytometry instruments, accessories, consumables and software …
WAT	Waters Corporation	72%	Reciprocal relationship from WAT graph: rs continuously introduce new products and have instrument businesses that are generally more diversified than the Company’s business. Some competitors have gr…
BECKMAN-COULTER-INC	BECKMAN-COULTER-INC	62%	ults of operations: The fol lowing table displays the benefit from income taxes for the three months ended March 31, 2026 and 2025 (in thousands): Three months ended March 31, Change 2026 2025 Amount…
DANAHER-CORPORATION-BIO-RAD-LABORATORIES-STANDAR	DANAHER-CORPORATION-BIO-RAD-LABORATORIES-STANDAR	62%	stics companies that design, manufacture and market flow cytometry instruments, accessories, consumables and software for cell analysis and/or provide services related to the same. An increasing numb…
DHR	Danaher Corporation	62%	Reciprocal relationship from DHR graph: Reciprocal relationship from CTKB graph: Reciprocal relationship from DHR graph: Reciprocal relationship from CTKB graph: stics companies that design, manufact…
FRANCE-CYTEK-LIMITED	FRANCE-CYTEK-LIMITED	62%	cing the next generation of cell analysis tools with its novel technical approach of leveraging the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on si…
GERMANY-CYTEK-BIOSCIENCES-LTD	GERMANY-CYTEK-BIOSCIENCES-LTD	62%	cing the next generation of cell analysis tools with its novel technical approach of leveraging the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on si…
NETHERLANDS-CYTEK-BIOSCIENCES-GMBH	NETHERLANDS-CYTEK-BIOSCIENCES-GMBH	62%	cing the next generation of cell analysis tools with its novel technical approach of leveraging the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on si…
UK-CYTEK-BIOSCIENCES-PTE-LTD	UK-CYTEK-BIOSCIENCES-PTE-LTD	62%	cing the next generation of cell analysis tools with its novel technical approach of leveraging the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on si…
WUXI-BIOSCIENCES-CO-LTD	WUXI-BIOSCIENCES-CO-LTD	62%	semblies. On August 25, 2021, we and Cytek (Wuxi) Biosciences Co., Ltd, our Wuxi, China subsidiary (“Cytek Wuxi”), entered into a Supply Agreement with Coherent NA, Inc. and certain of its affiliates…

Cytek Biosciences, Inc. Debt Obligations

Instrument	Description	Confidence	Evidence
CTKB-DEBT	Debt stack $27.5M	90%	Market cache reports total debt of $27.5M.

Cytek Biosciences, Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Cytek Biosciences, Inc..

Cytek Biosciences, Inc. Ownership

Holder	Name	Confidence	Evidence
CTKB-OWNER-BLACKROCK-INC	BlackRock, Inc.	90%	13F overlay lists BlackRock, Inc. as top holder; 166 tracked holders.

Cytek Biosciences, Inc. Extended Supply Chain Network

Ticker	Name	Chain Index	Hops	Relationship Types
BDX	Becton, Dickinson and Company	100.00	1	['customer', 'supplier']
DHR	Danaher Corporation	100.00	1	['customer']
WAT	Waters Corporation	100.00	1	['customer', 'supplier']
NAUT	Nautilus Biotechnology, Inc.	100.00	2
EW	Edwards Lifesciences Corporation	50.00	2
HBIO	Harvard Bioscience, Inc.	50.00	2
EMBC	Embecta Corp.	50.00	2
IINN	Inspira Technologies Oxy B.H.N. Ltd.	50.00	2
TMO	Thermo Fisher Scientific Inc.	50.00	2
PYPD	PolyPid Ltd.	50.00	2
CDNA	CareDx, Inc.	50.00	2
MMSI	Merit Medical Systems, Inc.	50.00	2
NVST	Envista Holdings Corporation	50.00	2
PRMB	Primo Brands Corporation	50.00	2
WATERS	WATERS	50.00	2
ANGO	AngioDynamics, Inc.	50.00	2
STE	STERIS plc	50.00	2
A	Agilent Technologies, Inc.	50.00	2
AORT	Artivion, Inc.	50.00	2
TELA	TELA Bio, Inc.	50.00	2

Cytek Biosciences, Inc. Supply Chain